Among the mechanisms that regulate PD-L1 expression, the production of cytokines, such as IL-1a, IL-27, IL-10, and IL-32g, in the tumor microenvironment (TME) can upregulate the expression of PD-L1 on monocytes and tumor cells [12,13]. The gene discussed is IL1A; the disease is neoplasm.